QPS Assay Finder
VALIDATED ASSAYS QPS
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
SEARCH FOR AN ASSAY HERE!
Found 835 Results
Darifenacin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 20,000 pg/mL |
| Sample Volume: | 0.5 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Urinary Tract |
| Classification: | Drug Assays |
Darifenacin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 30,000 pg/mL |
| Sample Volume: | 0.4 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Urinary Tract |
| Classification: | Drug Assays |
Darunavir (DRV) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 20 – 10,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Dasatinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Dasatinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 400 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Dasatinib (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.75 – 600 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Oncology |
| Classification: | Drug Assays |
Dehydroepiandrosterone (DHEA) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 0.500 – 250 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Dehydroepiandrosterone sulphate (DHEA-S) (Matrix: Human Serum)
| Matrix: | Human Serum |
| Assay Range: | 50.0 – 10,000 ng/mL |
| Sample Volume: | 0.02 mL |
| Anti-Coagulant: | N.Ap. |
| Storage Temperature (°C): | -20 |
| Platform: | LC-MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | N/A |
| Classification: | Biochemical Biomarkers |
Delavirdine (DLV)
Nevirapine (NVP) (Matrix: Human Plasma)
Nevirapine (NVP) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 1,000 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
Desipramine
Imipramine (Matrix: Human Plasma)
Imipramine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 2.00 – 200 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-NL |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Desipramine
Imipramine (Matrix: Human Plasma)
Imipramine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 1 – 2,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Desloratadine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 5 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Antihistamine |
| Classification: | Drug Assays |
Desloratadine
3-Hydroxydesloratadine (Matrix: Human Plasma)
3-Hydroxydesloratadine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.05 – 10 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antihistamine |
| Classification: | Drug Assays |
Desvenlafaxine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 600 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Desvenlafaxine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 250 ng/mL |
| Sample Volume: | 0.3 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antidepressant |
| Classification: | Drug Assays |
Dexamethasone (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 60 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Antiinflammatory |
| Classification: | Drug Assays |
Dexlansoprazole (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 10 – 5,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Gastrointestinal |
| Classification: | Drug Assays |
Dextromethorphan Dextrorphan (Matrix: Mouse Plasma)
| Matrix: | Mouse Plasma |
| Assay Range: | 0.2 – 100 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Dextromethorphan Dextrorphan Acetaminophen (Matrix: Dog Plasma)
| Matrix: | Dog Plasma |
| Assay Range: | 1 – 500 ng/mL |
| Sample Volume: | 0.05 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Dextromethorphan
Guaifenesin (Matrix: Human Plasma)
Guaifenesin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.06 – 40 ng/mL 10 – 6,000 ng/mL |
| Sample Volume: | 0.25 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC-MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Dextromethorphan
Guaifenesin (Matrix: Human Plasma)
Guaifenesin (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 100 – 32,000 pg/mL 10 – 5,000 ng/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 & -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-India |
| CLIA: | No |
| Therapy Area: | Respiratory |
| Classification: | Drug Assays |
Di-Demethyl Sibutramine (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 50 – 10,000 pg/mL |
| Sample Volume: | 0.2 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | Obesity |
| Classification: | Drug Assays |
Diclofenac (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 0.5 – 500 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | Heparin |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Taiwan |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Diclofenac (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 2,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -20 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | NSAID |
| Classification: | Drug Assays |
Didanosine (ddI)
Stavudine (d4T)
Zidovudine (AZT) (Matrix: Human Plasma)
Stavudine (d4T)
Zidovudine (AZT) (Matrix: Human Plasma)
| Matrix: | Human Plasma |
| Assay Range: | 5 – 3,000 ng/mL |
| Sample Volume: | 0.1 mL |
| Anti-Coagulant: | EDTA |
| Storage Temperature (°C): | -70 |
| Platform: | LC/MS/MS |
| Site: | QPS-Delaware |
| CLIA: | No |
| Therapy Area: | Antiviral – HIV |
| Classification: | Drug Assays |
DOWNLOAD THE FREE APPLE OR ANDROID APP HERE!
